+1 347 708 0418
Report Summary
Biological Drugs-Global Market Status and Trend Report 2015-2026 offers a comprehensive analysis on Biological Drugs industry, standing on the readers perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Biological Drugs 2015-2019, and development forecast 2020-2026
Main manufacturers/suppliers of Biological Drugs worldwide, with company and product introduction, position in the Biological Drugs market
Market status and development trend of Biological Drugs by types and applications
Cost and profit status of Biological Drugs, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Biological Drugs market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Biological Drugs industry.
The report segments the global Biological Drugs market as:
Global Biological Drugs Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2015-2026):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Biological Drugs Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2015-2026):
Therapeutic Protein
Monoclonal Antibody
Vaccine
Others
Global Biological Drugs Market: Application Segment Analysis (Consumption Volume and Market Share 2015-2026; Downstream Customers and Market Analysis)
Hospitals
Ambulatory Surgical Centers
Others
Global Biological Drugs Market: Manufacturers Segment Analysis (Company and Product introduction, Biological Drugs Sales Volume, Revenue, Price and Gross Margin):
Bristol-Myers Squibb
Merck
Pfizer
Eli Lilly
Johnson & Johnson
Takeda
Baxter
F. Hoffmann-La Roche
Amgen
Abbott Laboratories
Novartis
Biogen
GlaxoSmithKline
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Contents
Chapter 1 Overview of Biological Drugs
1.1 Definition of Biological Drugs in This Report
1.2 Commercial Types of Biological Drugs
1.2.1 Therapeutic Protein
1.2.2 Monoclonal Antibody
1.2.3 Vaccine
1.2.4 Others
1.3 Downstream Application of Biological Drugs
1.3.1 Hospitals
1.3.2 Ambulatory Surgical Centers
1.3.3 Others
1.4 Development History of Biological Drugs
1.5 Market Status and Trend of Biological Drugs 2015-2026
1.5.1 Global Biological Drugs Market Status and Trend 2015-2026
1.5.2 Regional Biological Drugs Market Status and Trend 2015-2026
Chapter 2 Global Market Status and Forecast by Regions
2.1 Market Development of Biological Drugs 2015-2019
2.2 Production Market of Biological Drugs by Regions
2.2.1 Production Volume of Biological Drugs by Regions
2.2.2 Production Value of Biological Drugs by Regions
2.3 Demand Market of Biological Drugs by Regions
2.4 Production and Demand Status of Biological Drugs by Regions
2.4.1 Production and Demand Status of Biological Drugs by Regions 2015-2019
2.4.2 Import and Export Status of Biological Drugs by Regions 2015-2019
Chapter 3 Global Market Status and Forecast by Types
3.1 Production Volume of Biological Drugs by Types
3.2 Production Value of Biological Drugs by Types
3.3 Market Forecast of Biological Drugs by Types
Chapter 4 Global Market Status and Forecast by Downstream Industry
4.1 Demand Volume of Biological Drugs by Downstream Industry
4.2 Market Forecast of Biological Drugs by Downstream Industry
Chapter 5 Market Driving Factor Analysis of Biological Drugs
5.1 Global Economy Situation and Trend Overview
5.2 Biological Drugs Downstream Industry Situation and Trend Overview
Chapter 6 Biological Drugs Market Competition Status by Major Manufacturers
6.1 Production Volume of Biological Drugs by Major Manufacturers
6.2 Production Value of Biological Drugs by Major Manufacturers
6.3 Basic Information of Biological Drugs by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Biological Drugs Major Manufacturer
6.3.2 Employees and Revenue Level of Biological Drugs Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
Chapter 7 Biological Drugs Major Manufacturers Introduction and Market Data
7.1 Bristol-Myers Squibb
7.1.1 Company profile
7.1.2 Representative Biological Drugs Product
7.1.3 Biological Drugs Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb
7.2 Merck
7.2.1 Company profile
7.2.2 Representative Biological Drugs Product
7.2.3 Biological Drugs Sales, Revenue, Price and Gross Margin of Merck
7.3 Pfizer
7.3.1 Company profile
7.3.2 Representative Biological Drugs Product
7.3.3 Biological Drugs Sales, Revenue, Price and Gross Margin of Pfizer
7.4 Eli Lilly
7.4.1 Company profile
7.4.2 Representative Biological Drugs Product
7.4.3 Biological Drugs Sales, Revenue, Price and Gross Margin of Eli Lilly
7.5 Johnson & Johnson
7.5.1 Company profile
7.5.2 Representative Biological Drugs Product
7.5.3 Biological Drugs Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.6 Takeda
7.6.1 Company profile
7.6.2 Representative Biological Drugs Product
7.6.3 Biological Drugs Sales, Revenue, Price and Gross Margin of Takeda
7.7 Baxter
7.7.1 Company profile
7.7.2 Representative Biological Drugs Product
7.7.3 Biological Drugs Sales, Revenue, Price and Gross Margin of Baxter
7.8 F. Hoffmann-La Roche
7.8.1 Company profile
7.8.2 Representative Biological Drugs Product
7.8.3 Biological Drugs Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche
7.9 Amgen
7.9.1 Company profile
7.9.2 Representative Biological Drugs Product
7.9.3 Biological Drugs Sales, Revenue, Price and Gross Margin of Amgen
7.10 Abbott Laboratories
7.10.1 Company profile
7.10.2 Representative Biological Drugs Product
7.10.3 Biological Drugs Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.11 Novartis
7.11.1 Company profile
7.11.2 Representative Biological Drugs Product
7.11.3 Biological Drugs Sales, Revenue, Price and Gross Margin of Novartis
7.12 Biogen
7.12.1 Company profile
7.12.2 Representative Biological Drugs Product
7.12.3 Biological Drugs Sales, Revenue, Price and Gross Margin of Biogen
7.13 GlaxoSmithKline
7.13.1 Company profile
7.13.2 Representative Biological Drugs Product
7.13.3 Biological Drugs Sales, Revenue, Price and Gross Margin of GlaxoSmithKline
Chapter 8 Upstream and Downstream Market Analysis of Biological Drugs
8.1 Industry Chain of Biological Drugs
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
Chapter 9 Cost and Gross Margin Analysis of Biological Drugs
9.1 Cost Structure Analysis of Biological Drugs
9.2 Raw Materials Cost Analysis of Biological Drugs
9.3 Labor Cost Analysis of Biological Drugs
9.4 Manufacturing Expenses Analysis of Biological Drugs
Chapter 10 Marketing Status Analysis of Biological Drugs
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Report Conclusion
Chapter 12 Research Methodology and Reference
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
List of Tables
Table Advantage and Disadvantage of Therapeutic Protein
Table Advantage and Disadvantage of Monoclonal Antibody
Table Advantage and Disadvantage of Vaccine
Table Advantage and Disadvantage of Others
Table Production Volume of Biological Drugs by Regions 2015-2019
Table Production Value of Biological Drugs by Regions 2015-2019
Table Demand Volume of Biological Drugs by Regions 2015-2019
Table Production and Demand Status of Biological Drugs in Region One 2015-2019
Table Production and Demand Status of Biological Drugs in Region Two 2015-2019
Table Production and Demand Status of Biological Drugs in Region Three 2015-2019
Table Production and Demand Status of Biological Drugs in Region Four 2015-2019
Table Import Volume of Biological Drugs by Regions 2015-2019
Table Export Volume of Biological Drugs by Regions 2015-2019
Table Production Volume of Biological Drugs by Types 2015-2019
Table Production Value of Biological Drugs by Types 2015-2019
Table Production Volume Forecast of Biological Drugs by Types 2020-2026
Table Production Value Forecast of Biological Drugs by Types 2020-2026
Table Demand Volume of Biological Drugs by Downstream Industry 2015-2019
Table Demand Volume Forecast of Biological Drugs by Downstream Industry 2020-2026
Table Production Volume of Biological Drugs by Major Manufacturers 2015-2019
Table Production Value of Biological Drugs by Major Manufacturers 2015-2019
Table Headquarters Location and Established Time of Biological Drugs Major Manufacturer
Table Employees and Revenue Level of Biological Drugs Major Manufacturer
Table Representative Biological Drugs Product One of Bristol-Myers Squibb
Table Representative Biological Drugs Product Two of Bristol-Myers Squibb
Table Biological Drugs Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb 2015-2019
Table Representative Biological Drugs Product One of Merck
Table Representative Biological Drugs Product Two of Merck
Table Biological Drugs Sales, Revenue, Price and Gross Margin of Merck 2015-2019
Table Representative Biological Drugs Product One of Pfizer
Table Representative Biological Drugs Product Two of Pfizer
Table Biological Drugs Sales, Revenue, Price and Gross Margin of Pfizer 2015-2019
Table Representative Biological Drugs Product One of Eli Lilly
Table Representative Biological Drugs Product Two of Eli Lilly
Table Biological Drugs Sales, Revenue, Price and Gross Margin of Eli Lilly 2015-2019
Table Representative Biological Drugs Product One of Johnson & Johnson
Table Representative Biological Drugs Product Two of Johnson & Johnson
Table Biological Drugs Sales, Revenue, Price and Gross Margin of Johnson & Johnson 2015-2019
Table Representative Biological Drugs Product One of Takeda
Table Representative Biological Drugs Product Two of Takeda
Table Biological Drugs Sales, Revenue, Price and Gross Margin of Takeda 2015-2019
Table Representative Biological Drugs Product One of Baxter
Table Representative Biological Drugs Product Two of Baxter
Table Biological Drugs Sales, Revenue, Price and Gross Margin of Baxter 2015-2019
Table Representative Biological Drugs Product One of F. Hoffmann-La Roche
Table Representative Biological Drugs Product Two of F. Hoffmann-La Roche
Table Biological Drugs Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche 2015-2019
Table Representative Biological Drugs Product One of Amgen
Table Representative Biological Drugs Product Two of Amgen
Table Biological Drugs Sales, Revenue, Price and Gross Margin of Amgen 2015-2019
Table Representative Biological Drugs Product One of Abbott Laboratories
Table Representative Biological Drugs Product Two of Abbott Laboratories
Table Biological Drugs Sales, Revenue, Price and Gross Margin of Abbott Laboratories 2015-2019
Table Representative Biological Drugs Product One of Novartis
Table Representative Biological Drugs Product Two of Novartis
Table Biological Drugs Sales, Revenue, Price and Gross Margin of Novartis 2015-2019
Table Representative Biological Drugs Product One of Biogen
Table Representative Biological Drugs Product Two of Biogen
Table Biological Drugs Sales, Revenue, Price and Gross Margin of Biogen 2015-2019
Table Representative Biological Drugs Product One of GlaxoSmithKline
Table Representative Biological Drugs Product Two of GlaxoSmithKline
Table Biological Drugs Sales, Revenue, Price and Gross Margin of GlaxoSmithKline 2015-2019
List of Figures
Figure Representative Commercial Product Picture of Biological Drugs
Figure Global Shipments Volume Share of Biological Drugs by Types in 2019
Figure Representative Commercial Product Picture of Therapeutic Protein
Figure Representative Commercial Product Picture of Monoclonal Antibody
Figure Representative Commercial Product Picture of Vaccine
Figure Representative Commercial Product Picture of Others
Figure Demand Volume Share of Biological Drugs by Downstream Industry in 2019
Figure Hospitals Examples of Biological Drugs
Figure Ambulatory Surgical Centers Examples of Biological Drugs
Figure Others Examples of Biological Drugs
Figure Global Biological Drugs Revenue and Growth Rate 2015-2026
Figure Global Biological Drugs Market Size Comparison in 2015, 2019 and 2026
Figure North America Biological Drugs Revenue and Growth Rate 2015-2026
Figure Europe Biological Drugs Revenue and Growth Rate 2015-2026
Figure China Biological Drugs Revenue and Growth Rate 2015-2026
Figure Japan Biological Drugs Revenue and Growth Rate 2015-2026
Figure Rest APAC Biological Drugs Revenue and Growth Rate 2015-2026
Figure Latin America Biological Drugs Revenue and Growth Rate 2015-2026
Figure Production Volume and Growth Rate of Biological Drugs 2015-2019
Figure Production Value and Growth Rate of Biological Drugs 2015-2019
Figure Production Volume Share of Biological Drugs by Regions 2015-2019
Figure Production Volume Share of Biological Drugs by Regions in 2015
Figure Production Volume Share of Biological Drugs by Regions in 2019
Figure Production Volume Growth Rate Comparison of Biological Drugs by Regions 2015-2019
Figure Production Value Share of Biological Drugs by Regions 2015-2019
Figure Production Value Share of Biological Drugs by Regions in 2015
Figure Production Value Share of Biological Drugs by Regions in 2019
Figure Production Value Growth Rate Comparison of Biological Drugs by Regions 2015-2019
Figure Demand Volume Share of Biological Drugs by Regions 2015-2019
Figure Demand Volume Share of Biological Drugs by Regions in 2015
Figure Demand Volume Share of Biological Drugs by Regions in 2019
Figure Demand Volume Growth Rate Comparison of Biological Drugs by Regions 2015-2019
Figure Production Volume Share of Biological Drugs by Types 2015-2019
Figure Production Volume Share of Biological Drugs by Types in 2015
Figure Production Volume Share of Biological Drugs by Types in 2019
Figure Production Volume Growth Rate Comparison of Biological Drugs by Types 2015-2019
Figure Production Value Share of Biological Drugs by Types 2015-2019
Figure Production Value Share of Biological Drugs by Types in 2015
Figure Production Value Share of Biological Drugs by Types in 2019
Figure Production Value Growth Rate Comparison of Biological Drugs by Types 2015-2019
Figure Production Volume Share Forecast of Biological Drugs by Types in 2026
Figure Production Value Share Forecast of Biological Drugs by Types in 2026
Figure Demand Volume Share of Biological Drugs by Downstream Industry 2015-2019
Figure Demand Volume Share of Biological Drugs by Downstream Industry in 2015
Figure Demand Volume Share of Biological Drugs by Downstream Industry in 2019
Figure Demand Volume Growth Rate Comparison of Biological Drugs by Downstream Industry 2015-2019
Figure Demand Volume Share Forecast of Biological Drugs by Downstream Industry in 2026
Figure Production Volume Share of Biological Drugs by Major Manufacturers in 2015
Figure Production Volume Share of Biological Drugs by Major Manufacturers in 2019
Figure Production Value Share of Biological Drugs by Major Manufacturers in 2015
Figure Production Value Share of Biological Drugs by Major Manufacturers in 2019
Figure Biological Drugs Revenue and Market Share of Bristol-Myers Squibb 2015-2019
Figure Biological Drugs Revenue and Market Share of Merck 2015-2019
Figure Biological Drugs Revenue and Market Share of Pfizer 2015-2019
Figure Biological Drugs Revenue and Market Share of Eli Lilly 2015-2019
Figure Biological Drugs Revenue and Market Share of Johnson & Johnson 2015-2019
Figure Biological Drugs Revenue and Market Share of Takeda 2015-2019
Figure Biological Drugs Revenue and Market Share of Baxter 2015-2019
Figure Biological Drugs Revenue and Market Share of F. Hoffmann-La Roche 2015-2019
Figure Biological Drugs Revenue and Market Share of Amgen 2015-2019
Figure Biological Drugs Revenue and Market Share of Abbott Laboratories 2015-2019
Figure Biological Drugs Revenue and Market Share of Novartis 2015-2019
Figure Biological Drugs Revenue and Market Share of Biogen 2015-2019
Buy
